{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T06:13:38Z","timestamp":1785392018269,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s13555-021-00674-x","type":"journal-article","created":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T05:02:30Z","timestamp":1641618150000},"page":"285-293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Dapsone in Hidradenitis Suppurativa: A Systematic Review"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2038-6492","authenticated-orcid":false,"given":"Aswatha","family":"Rabindranathnambi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balasubramanian","family":"Jeevankumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,8]]},"reference":[{"key":"674_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","volume":"60","author":"A Alikhan","year":"2009","unstructured":"Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60:539\u201361.","journal-title":"J Am Acad Dermatol"},{"key":"674_CR2","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/bjd.16231","volume":"178","author":"A Pink","year":"2018","unstructured":"Pink A, Anzengruber F, Navarini AA. Acne and hidradenitis suppurativa. Br J Dermatol. 2018;178:619\u201331.","journal-title":"Br J Dermatol"},{"key":"674_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-2133.2010.10034.x","volume":"164","author":"M Von Laffert","year":"2011","unstructured":"Von Laffert M, Stadie V, Wohlrab J, Marsch WC. Hidradenitis suppurativa\/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br J Dermatol. 2011;164:367\u201371.","journal-title":"Br J Dermatol"},{"key":"674_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","volume":"29","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Desai N, Emtestam L, et al. European S1 for the treatment of hidradenitis suppurativa\/acne inversa. J Eur Acad Dermatol Venereol. 2015;29:619\u201344.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"674_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ajog.2020.09.036","volume":"224","author":"EK Collier","year":"2020","unstructured":"Collier EK, Parvataneni RK, Lowes MA, et al. Diagnosis and management of hidradenitis suppurativa in women. Am J Obstet Gynecol. 2020;224(1):54\u201361.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"674_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.1468-3083.2009.03356.x","volume":"23","author":"JE Revuz","year":"2009","unstructured":"Revuz JE. Hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2009;23(9):985\u201398.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"674_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMcp1014163","volume":"366","author":"GB Jemec","year":"2012","unstructured":"Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366:158\u201364.","journal-title":"N Engl J Med"},{"key":"674_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000443878","volume":"232","author":"D Lipsker","year":"2016","unstructured":"Lipsker D, Severac F, Freysz M, et al. The ABC of hidradenitis suppurativa: a validated glossary on how to name lesions. Dermatology. 2016;232:137\u201342.","journal-title":"Dermatology"},{"key":"674_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jaad.2017.02.005","volume":"77","author":"A Garg","year":"2017","unstructured":"Garg A, Lavian J, Lin G, Strunk A, Alloo A. Incidence of hidradenitis suppurativa in the United States: a sex- and age-adjusted population analysis. J Am Acad Dermatol. 2017;77:118\u201322.","journal-title":"J Am Acad Dermatol"},{"key":"674_CR10","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","volume":"153","author":"A Garg","year":"2017","unstructured":"Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol. 2017;153:760\u20134.","journal-title":"JAMA Dermatol"},{"key":"674_CR11","first-page":"729","volume-title":"Dermatologic surgery","author":"HJ Hurley","year":"1989","unstructured":"Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: Roenigk RK, Roenigk HH, editors. Dermatologic surgery. New York: Marcel Dekker; 1989. p. 729\u201339."},{"key":"674_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1046\/j.1365-2133.2003.05390.x","volume":"149","author":"K Sartorius","year":"2003","unstructured":"Sartorius K, Lapins J, Emtestam L, Jemec GB. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol. 2003;149:211\u20133.","journal-title":"Br J Dermatol"},{"key":"674_CR13","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","volume":"161","author":"K Sartorius","year":"2009","unstructured":"Sartorius K, Emtestam L, Jemec GB, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol. 2009;161:831\u20139.","journal-title":"Br J Dermatol"},{"issue":"2","key":"674_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000431175","volume":"231","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Del MV, Mrowietz U, et al. Hidradenitis suppurativa\/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology. 2015;231(2):184\u201390.","journal-title":"Dermatology"},{"issue":"3","key":"674_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11154-016-9328-5","volume":"17","author":"W Gulliver","year":"2016","unstructured":"Gulliver W, Zouboulis CC, Prens E, Jemec GB, Tzellos T. Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa. Rev Endocr Metab Disord. 2016;17(3):343\u201351.","journal-title":"Rev Endocr Metab Disord"},{"key":"674_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","volume":"82","author":"A Garg","year":"2020","unstructured":"Garg A, Neuren E, Cha D, et al. Evaluating patients\u2019 unmet needs in hidradenitis suppurativa: results from the Global Survey of Impact and Healthcare Needs (VOICE) project. J Am Acad Dermatol. 2020;82:366\u201376.","journal-title":"J Am Acad Dermatol"},{"key":"674_CR17","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/bjd.14038","volume":"173","author":"DM Saunte","year":"2015","unstructured":"Saunte DM, Boer J, Stratigos A, et al. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol. 2015;173:1546\u20139.","journal-title":"Br J Dermatol"},{"key":"674_CR18","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/bjd.14024","volume":"173","author":"T Tzellos","year":"2015","unstructured":"Tzellos T, Zouboulis CC, Gulliver W, et al. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2015;173:1142\u201355.","journal-title":"Br J Dermatol"},{"key":"674_CR19","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.clindermatol.2016.10.018","volume":"35","author":"RK Andersen","year":"2017","unstructured":"Andersen RK, Jemec GBE. Treatments for hidradenitis suppurativa. Clin Dermatol. 2017;35:218\u201324.","journal-title":"Clin Dermatol"},{"key":"674_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-4362.1983.tb02150.x","volume":"22","author":"OJ Clemmensen","year":"1983","unstructured":"Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol. 1983;22:325\u20138.","journal-title":"Int J Dermatol"},{"key":"674_CR21","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","volume":"39","author":"GB Jemec","year":"1998","unstructured":"Jemec GB, Wendelbee P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 1998;39:971\u20134.","journal-title":"J Am Acad Dermatol"},{"key":"674_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000321716","volume":"222","author":"O Join-Lambert","year":"2011","unstructured":"Join-Lambert O, Coignard H, Jais JP, et al. Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa. Dermatology. 2011;222:49\u201358.","journal-title":"Dermatology"},{"key":"674_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jaad.2016.08.001","volume":"76","author":"AH Fischer","year":"2017","unstructured":"Fischer AH, Haskin A, Okoye GA. Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa. J Am Acad Dermatol. 2017;76:309\u201313.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"674_CR24","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/bjd.19136","volume":"183","author":"G Murray","year":"2020","unstructured":"Murray G, Hollywood A, Kirby B, Hughes R. Dapsone therapy for hidradenitis suppurativa. Br J Dermatol. 2020;183(4):767\u20138.","journal-title":"Br J Dermatol"},{"key":"674_CR25","doi-asserted-by":"crossref","unstructured":"Wozel G, Blasum C. Dapsone in dermatology and beyond. Arch Dermatol\nRes. 2014;306(2):103\u201324","DOI":"10.1007\/s00403-013-1409-7"},{"key":"674_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/1523-1747.ep12555654","volume":"98","author":"SA Booth","year":"1992","unstructured":"Booth SA, Moody CE, Dahl MV, Herron MJ, Nelson RD. Dapsone suppresses integrin-mediated neutrophil adherence function. J Invest Dermatol. 1992;98:135\u201340.","journal-title":"J Invest Dermatol"},{"key":"674_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/000155501750208146","volume":"81","author":"J Lapins","year":"2001","unstructured":"Lapins J, Asman B, Gustafsson A, Bergstrom K, Emtestam L. Neutrophil-related host response in hidradenitis suppurativa\u2014a pilot study of patients with inactive disease. Acta Derm Venereol. 2001;81:96\u20139.","journal-title":"Acta Derm Venereol"},{"key":"674_CR28","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s001050170015","volume":"52","author":"T Hofer","year":"2001","unstructured":"Hofer T, Itin PH. Acne inverse. Eine dapson-sensitive dermatose [Acne inverse: a dapsone-sensitive dermatitis]. Hautarzt. 2001;52:989\u201392.","journal-title":"Hautarzt"},{"key":"674_CR29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1067\/mjd.2001.114733","volume":"45","author":"YI Zhu","year":"2001","unstructured":"Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol. 2001;45:420\u201334.","journal-title":"J Am Acad Dermatol"},{"key":"674_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2174\/157016309789869065","volume":"6","author":"M Kasperkiewicz","year":"2009","unstructured":"Kasperkiewicz M, Schmidt E. Current treatment of autoimmune blistering diseases. Curr Drug Discov Technol. 2009;6:270\u201380.","journal-title":"Curr Drug Discov Technol"},{"issue":"4","key":"674_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/09546630600830588","volume":"17","author":"MR Kaur","year":"2006","unstructured":"Kaur MR, Lewis HM. Hidradenitis suppurativa treated with dapsone: a case series of five patients. J Dermatolog Treat. 2006;17(4):211\u20133.","journal-title":"J Dermatolog Treat"},{"key":"674_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1159\/000329023","volume":"222","author":"S Yazdanyar","year":"2011","unstructured":"Yazdanyar S, Boer J, Ingvarsson G, Szepietowski JC, Jemec GBE. Dapsone therapy for hidradenitis suppurativa: a series of 24 patients. Dermatology. 2011;222:342\u20136.","journal-title":"Dermatology"},{"issue":"5","key":"674_CR33","first-page":"319","volume":"113","author":"P Kozub","year":"2012","unstructured":"Kozub P, Simaljakova M. Hidradenitis suppurativa treated with combination of infliximab and dapsone. Bratisl Lek Listy. 2012;113(5):319\u201323.","journal-title":"Bratisl Lek Listy"},{"key":"674_CR34","doi-asserted-by":"crossref","unstructured":"Bashyam AM, Baroudi B, Feldman S, Pichardo RO. Dapsone to treat moderate to severe hidradenitis suppurativa: a retrospective case series. J Am Acad Dermatol. 2020;83(6).","DOI":"10.1016\/j.jaad.2020.06.259"},{"key":"674_CR35","doi-asserted-by":"publisher","unstructured":"Lopez-Llunell C, Riera-Marti N, Gamissans M, Romani J. Dapsone in hidradenitis suppurativa: a case series of 56 patients. Dermatol Ther. 2021:15161. https:\/\/doi.org\/10.1111\/dth.15161.","DOI":"10.1111\/dth.15161"},{"issue":"5","key":"674_CR36","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/bjd.17537","volume":"180","author":"JR Ingram","year":"2019","unstructured":"Ingram JR, Collier F, Brown D, et al. British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018. Br J Dermatol. 2019;180(5):1009\u201317.","journal-title":"Br J Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00674-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-021-00674-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-021-00674-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T03:13:54Z","timestamp":1645067634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-021-00674-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["674"],"URL":"https:\/\/doi.org\/10.1007\/s13555-021-00674-x","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,8]]},"assertion":[{"value":"23 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}